A modular strategy to develop HSA-based DOX prodrug nanoparticles for safe and effective tumor therapy

Chinese Chemical Letters 2026

View at publisher

Authors: Jialin Xing, Ziyi Wang, Yingbo Ma, Minglong Huang, Yafan Xiao, Lurong Zhang, Jin Sun, Jin Sun, Zhonggui He, Bingjun Sun, Lingxiao Li

DOI: 10.1016/j.cclet.2026.112386

Cited by: 1

References: 27

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Protein Interaction Studies and Fluorescence Analysis Nanoplatforms for cancer theranostics

References 27